Literature DB >> 22259144

Techniques for assessment of interactions of mucins with microbes and parasites in vitro and in vivo.

Yong H Sheng1, Sumaira Z Hasnain, Chin Wen Png, Michael A McGuckin, Sara K Lindén.   

Abstract

Most mammalian pathogens and parasites infect their hosts via the mucosal surfaces. The first barrier they encounter in all mucosal tissues is a layer of viscous mucus which can be modulated by immune responses to the pathogen or parasite. The major macromolecular constituents of mucus are secreted mucin glycoproteins which give mucus its viscous properties. Underneath the mucus layer, the mucosal epithelial cells have a cell surface glycocalyx that is rich in transmembrane mucin glycoproteins. Both the cell surface and secreted mucins present a vast array of potential binding sites for pathogens and parasites and both forms of mucins are involved in protecting the host from infection. However, many pathogens and parasites have evolved mechanisms to subvert the mucin barrier. Thus, studying mucin interactions with pathogens and parasites is critical to understanding host-pathogen interactions at the mucosal surfaces. In this chapter, we describe methods for studying the interactions between mucins and pathogens and parasites, methods for studying the degradation of mucins by pathogens and parasites, and in vitro and in vivo methods for exploring the functional significance of the mucins in host defence from infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22259144     DOI: 10.1007/978-1-61779-513-8_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  The cell surface mucin MUC1 limits the severity of influenza A virus infection.

Authors:  J L McAuley; L Corcilius; H-X Tan; R J Payne; M A McGuckin; L E Brown
Journal:  Mucosal Immunol       Date:  2017-03-22       Impact factor: 7.313

2.  Worm expulsion of Gymnophalloides seoi from C57BL/6 mice: role of metacercarial exosomes in upregulating TLR2 and MUC2 expression in intestinal tissues.

Authors:  Hyemi Song; Bong-Kwang Jung; Jaeeun Cho; Jong-Yil Chai
Journal:  Parasitol Res       Date:  2018-07-17       Impact factor: 2.289

3.  Lubiprostone stimulates small intestinal mucin release.

Authors:  Robert C De Lisle
Journal:  BMC Gastroenterol       Date:  2012-11-06       Impact factor: 3.067

4.  SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.

Authors:  Barbara Nesta; Maria Valeri; Angela Spagnuolo; Roberto Rosini; Marirosa Mora; Paolo Donato; Christopher J Alteri; Mariangela Del Vecchio; Scilla Buccato; Alfredo Pezzicoli; Isabella Bertoldi; Lapo Buzzigoli; Giovanna Tuscano; Maria Falduto; Valentina Rippa; Yaqoub Ashhab; Giuliano Bensi; Maria Rita Fontana; Kate L Seib; Harry L T Mobley; Mariagrazia Pizza; Marco Soriani; Laura Serino
Journal:  PLoS Pathog       Date:  2014-05-08       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.